FDA PMA FDA Class 3 Approved 🇺🇸 United States

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

PMA: P010031 · Supplement: S897 · Decision Sep 9, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P010031 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Trade Name
Cardiac Resynchronization Therapy -Defibrillator (CRT-D)
PMA Number
P010031
Supplement Number
S897
Device Class
FDA Class 3
Product Code
NIK
Generic Name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
September 9, 2025
Date Received
July 11, 2025
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Labeling Change - PAS
Expedited Review
N

Advisory Committee Statement

approval for a labeling update to include the findings of the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)